Trials / Completed
CompletedNCT00254813
Fast Titration Of Quetiapine Versus Currently Approved Titration
Fast Titration Of Quetiapine Versus Currently Approved Titration: A Randomised, Multicentre, Parallel Group Open Trial In Schizophrenia And Schizoaffective Disorder
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 150 (planned)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and tolerability of a more rapid dose titration in acute schizophrenic patients compared to the conventional titration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Quetiapine |
Timeline
- Start date
- 2004-10-01
- Completion
- 2005-09-01
- First posted
- 2005-11-17
- Last updated
- 2011-01-26
Locations
7 sites across 1 country: Norway
Source: ClinicalTrials.gov record NCT00254813. Inclusion in this directory is not an endorsement.